A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women

From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2024-5-18
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Xu X, Zhang Y, Yu L, Shi X, Min M, Xiong L, Pan J, Liu P, Wu G, Gao G
Journal
Scientific reports
Year
2022
Bacterial vaginosis (BV) is a genital infection that frequently presents in women infected with human papillomavirus (HPV), but the correlation between BV, HPV and cervical intraepithelial neoplasia (CIN) development is still elusive. We organized a cross-sectional analysis which enrolled 624 participants and obtained 423 samples of vaginal secretions from them, including 193 HPV-negative samples and 230 HR-HPV-positive samples. We used 16S rRNA sequencing to measure the vaginal microbiota diversity in women with different BV, HPV and CIN status, and then calculated risk factors for CIN by logistic regression. We found that the diversity of vaginal microbiota was significantly increased after BV, HPV and BV-infected CIN group. The Observed species and Chao1 index of H.C group showed little difference with normal group, while its Shannon index was considerable higher than normal group. L. iners enriched in HPV infection group compared with others significantly. BV (OR = 0.358; 95% CI = 0.195-0.656; P < .05) and HR-HPV infection (OR = 0.016; 95% CI = 0.004-0.072; P < .001) were risk factors for CIN. In conclusion, we consider BV as a risk factor for CIN. The enrichment of L. iners under HPV infection state may contribute to maintenance of vaginal dysbiosis, and BV infection could facilitate the disturb.

Experiment 1


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/21

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Uterine cervix , Vaginal fluid Canalis cervicis uteri,Caudal segment of uterus,Cervical canal,Cervical canal of uterus,Cervix,Cervix of uterus,Cervix uteri,Neck of uterus,Uterine cervix,uterine cervix,Vaginal discharge,Vaginal secretion,Vaginal fluid,vaginal fluid
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Vaginal microbiome measurement vaginal flora measurement,vaginal microbiota measurement,Vaginal microbiome measurement,vaginal microbiome measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Normal Healthy Women & High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Bacterial Vaginosis (BV) Infected Women
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with Bacterial Vaginosis (BV) Infection.
Group 0 sample size Number of subjects in the control (unexposed) group
136
Group 1 sample size Number of subjects in the case (exposed) group
52
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
30 days

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
4


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/22

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Figure 5A

Description: Bacterial Taxa differentially abundant in the vaginal microbiome of Bacterial Vaginosis (BV) Infected women compared to Normal healthy women & High‑risk human papillomavirus(HR-HPV) Infected Women as determined by LEfSe Analysis.

Abundance in Group 1: increased abundance in Bacterial Vaginosis (BV) Infected Women

NCBI Quality ControlLinks
Bacteroidales
Bacteroidia
Bacteroidota
Hoylesella timonensis
Prevotella
Prevotellaceae

Revision editor(s): Joan Chuks

Experiment 2


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/22

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Normal Healthy Women & Bacterial Vaginosis (BV) Infected Women
Group 1 name Corresponds to the case (exposed) group for case-control studies
High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with High‑risk human papillomavirus (HR-HPV) infection.
Group 0 sample size Number of subjects in the control (unexposed) group
117
Group 1 sample size Number of subjects in the case (exposed) group
71

Lab analysis

Statistical Analysis

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/22

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Figure 5A

Description: Bacterial Taxa differentially abundant in the vaginal microbiome of High‑risk human papillomavirus(HR-HPV) Infected Women compared to Normal healthy women & Bacterial Vaginosis (BV) Infected Women as determined by LEfSe Analysis.

Abundance in Group 1: increased abundance in High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)

NCBI Quality ControlLinks
Lactobacillus iners

Revision editor(s): Joan Chuks

Experiment 3


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/22

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Normal Healthy Women
Group 1 name Corresponds to the case (exposed) group for case-control studies
Bacterial vaginosis (BV) infected women & High‑risk human papillomavirus (HR-HPV) (HPV) infected Women
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with Bacterial vaginosis (BV) infection and those diagnosed with High‑risk human papillomavirus (HR-HPV) infection.
Group 0 sample size Number of subjects in the control (unexposed) group
65
Group 1 sample size Number of subjects in the case (exposed) group
123

Lab analysis

Statistical Analysis

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/22

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Source: Figure 5A

Description: Bacterial Taxa differentially abundant in the vaginal microbiome of Bacterial Vaginosis (BV) infected women and High‑risk human papillomavirus (HR-HPV) infected women compared to Normal healthy women as determined by LEfSe Analysis.

Abundance in Group 1: decreased abundance in Bacterial vaginosis (BV) infected women & High‑risk human papillomavirus (HR-HPV) (HPV) infected Women

NCBI Quality ControlLinks
Bacilli
Bacillota
Lactobacillaceae
Lactobacillales
Lactobacillus

Revision editor(s): Joan Chuks

Experiment 4


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/23

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
High‑risk human papillomavirus(HR-HPV) & Cervical Intraepithelial Neoplasia(CIN) co-infected women (HC)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with infection of High‑risk human papillomavirus (HR-HPV) combined with Cervical Intraepithelial Neoplasia (CIN).
Group 1 sample size Number of subjects in the case (exposed) group
48

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
unchanged
Richness Number of species
unchanged

Experiment 5


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/23

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Bacteial Vaginosis (BV) & High‑risk human papillomavirus(HR-HPV) with Cervical Intraepithelial Neoplasia(CIN) co-infected women (BHC)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with co-infection of Bacteial Vaginosis (BV) & High‑risk human papillomavirus (HR-HPV) in combination with Cervical Intraepithelial Neoplasia (CIN).
Group 1 sample size Number of subjects in the case (exposed) group
46

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased

Experiment 6


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/23

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Bacterial Vaginosis (BV) Infected Women
Group 1 name Corresponds to the case (exposed) group for case-control studies
High‑risk human papillomavirus(HR-HPV) & Cervical Intraepithelial Neoplasia(CIN) co-infected women (HC)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with infection of High‑risk human papillomavirus (HR-HPV) combined with Cervical Intraepithelial Neoplasia (CIN).
Group 0 sample size Number of subjects in the control (unexposed) group
52
Group 1 sample size Number of subjects in the case (exposed) group
48

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased
Richness Number of species
decreased

Experiment 7


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/23

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
High‑risk human papillomavirus (HR-HPV) Infected Women (HPV)
Group 0 sample size Number of subjects in the control (unexposed) group
71

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
decreased
Richness Number of species
decreased

Experiment 8


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/23

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Bacterial vaginosis (BV) and High‑risk human papillomavirus (HR-HPV) (HPV) co-infected Women (BH)
Group 0 sample size Number of subjects in the control (unexposed) group
60

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased

Experiment 9


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/23

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Bacteial Vaginosis (BV) & High‑risk human papillomavirus(HR-HPV) with Cervical Intraepithelial Neoplasia(CIN) co-infected women (BHC)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with with co-infection of Bacteial Vaginosis (BV) & High‑risk human papillomavirus (HR-HPV) in combination with Cervical Intraepithelial Neoplasia (CIN).
Group 0 sample size Number of subjects in the control (unexposed) group
71
Group 1 sample size Number of subjects in the case (exposed) group
46

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased

Experiment 10


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/04/23

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
High‑risk human papillomavirus(HR-HPV) & Cervical Intraepithelial Neoplasia(CIN) co-infected women (HC)
Group 0 sample size Number of subjects in the control (unexposed) group
48

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased

Experiment 11


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/05/17

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Normal Healthy Women
Group 1 name Corresponds to the case (exposed) group for case-control studies
Bacterial Vaginosis (BV) Infected Women
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with Bacterial Vaginosis (BV) Infection.
Group 0 sample size Number of subjects in the control (unexposed) group
65
Group 1 sample size Number of subjects in the case (exposed) group
52

Lab analysis

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
Not specified

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased

Experiment 12


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/05/17

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
High‑risk human papillomavirus(HR-HPV) Infected Women (HPV)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with High‑risk human papillomavirus (HR-HPV) infection.
Group 1 sample size Number of subjects in the case (exposed) group
71

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased

Experiment 13


Reviewed Marked as Reviewed by Svetlana up on 2024-5-18

Curated date: 2024/05/17

Curator: Joan Chuks

Revision editor(s): Joan Chuks

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Bacterial vaginosis (BV) and High‑risk human papillomavirus (HR-HPV) (HPV) co-infected Women (BH)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Women attending the Aviation General hospital, located in Beijing, China, who were diagnosed with co-infection of Bacterial vaginosis (BV) and High‑risk human papillomavirus (HR-HPV).

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
increased
Richness Number of species
increased